X, G., Z, Y., Y, T., L, Z., W, X., X, S., . . . H, L. (2026). Computed tomography-derived body composition and early changes predict outcomes of first-line chemo-immunotherapy in recurrent/metastatic nasopharyngeal carcinoma. The oncologist, 31(10), . https://doi.org/10.1093/oncolo/oyag355
Chicago Style (17th ed.) CitationX, Gan, et al. "Computed Tomography-derived Body Composition and Early Changes Predict Outcomes of First-line Chemo-immunotherapy in Recurrent/metastatic Nasopharyngeal Carcinoma." The Oncologist 31, no. 10 (2026). https://doi.org/10.1093/oncolo/oyag355.
MLA (9th ed.) CitationX, Gan, et al. "Computed Tomography-derived Body Composition and Early Changes Predict Outcomes of First-line Chemo-immunotherapy in Recurrent/metastatic Nasopharyngeal Carcinoma." The Oncologist, vol. 31, no. 10, 2026, https://doi.org/10.1093/oncolo/oyag355.